InteliCare Holdings Limited (ASX: ICR) - Share Price
- Current share price for ICR : $0.022
InteliCare Holdings Limited (ICR), an ASX-listed company, is a Company that is engaged in production of a predictive analytics solution for care providers in the aged care, disability and healthcare sectors, sales and marketing, research and development activities.
ICR General Information +
| ASX Code | ICR |
| Website | http://www.intelicare.com.au |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 15 |
| ICR Share Price | $0.022 |
| Day High | $0.000 |
| Day Low | $0.000 |
| Last Close | $0.022 |
| ICR Share Price Movement | - ( No change ) |
Prices as at 16:40, 24 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
InteliCare Holdings Limited (ICR) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from InteliCare Holdings Limited (ICR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
InteliCare Holdings Limited (ICR) price-sensitive announcements
ICR - Investor Presentation
The document, dated 21 April 2026, presents an investor presentation for InteliCare Holdin
InteliCare Holdings Limited (ICR)
16 Jun 2026 | 8:15 AM
16 Jun 2026 | 8:15 AM
ICR - InteliCare Completes $2.05m Placement to Support Scale-Up
InteliCare Holdings Limited, an Australian technology company, has announced the completio
InteliCare Holdings Limited (ICR)
7 May 2026 | 9:32 AM
7 May 2026 | 9:32 AM
ICR - Trading Halt
Intelicare Holdings Limited (ASX: ICR) has requested a trading halt on its securities pend
InteliCare Holdings Limited (ICR)
5 May 2026 | 9:09 AM
5 May 2026 | 9:09 AM
ICR - March 2026 Quarterly Operations Report
InteliCare Holdings Ltd reported significant achievements in their March 2026 quarterly op
InteliCare Holdings Limited (ICR)
30 Apr 2026 | 5:45 PM
30 Apr 2026 | 5:45 PM
InteliCare Holdings Limited (ICR) Recent ASX Announcements
ICR Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$2.24 | -$0.50 | -51.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$2.26 | -$1.00 | -44.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$3.00 | -$1.80 | -47.20% | 0.00 | 0.00 | 0.00% | 0.0% |
ICR Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| 4DMedical Limited (4DX) | $2,816M | 0.3304 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| InteliCare Holdings Limited (ICR) | $16M | -0.5100 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $18,066M | 0.3919 | 0.2545 | 0.2962 | 157.0663 | 125.2027 | 96.5927 | 0.32% | 0.41% | 0.53% |
ICR Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | -12.90 | 0.00 |
| Market | 0.29 | 13.20 | 1.16 | 0.69 |
| Sector | 0.57 | 20.50 | 1.61 | 2.49 |
ICR Directors
| Name | Position | Start Date |
|---|---|---|
| Dr Neale William Fong | Non-Executive Chairman, Non-Executive Director | 21 Apr 2022 |
| Mr Timothy (Tim) Chapman | Non-Executive Director | 25 Sep 2024 |
| Mr Greg Leach | Non-Executive Director | 1 Jan 0001 |
InteliCare Holdings Limited (ICR) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 15 Dec 2025 | CHAPMAN, Timothy (Tim) | Issued | Related Securities | 6,000,000 | $0.020 | $120,000.000 |
| 15 Dec 2025 | LEACH, Greg | Issued | Related Securities | 4,500,000 | $0.018 | $80,000.000 |
| 15 Dec 2025 | FONG, Neale | Issued | Related Securities | 4,500,000 | $0.018 | $80,000.000 |
See all changes in directors' interest & trades for InteliCare Holdings Limited (ICR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
ICR Management
| Name | Position |
|---|---|
| Daniel Pilbrow | Chief Executive Officer |
| Mike Tappenden | Chief Technology Officer |
| Neil John Hackett | Company Secretary |
ICR Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in InteliCare Holdings Limited (ICR). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 33,060,387 (5.43%) | Melbourne Securities Corporation Limited |
| 30,936,145 (5.01%) | Citicorp Nominees Pty Limited |
ICR Calendar of Events
| Date | Event |
|---|---|
| 26 February 2027 | Report (Interim) |
| 19 October 2026 | Report (Annual) |
| 28 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
